A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Zopiclone
4-hydroxycoumarin
Dabigatran etexilate may increase the anticoagulant activities of 4-hydroxycoumarin.
Zopiclone
Epoprostenol
Dabigatran etexilate may increase the anticoagulant activities of Epoprostenol.
Zopiclone
Enoxaparin
Dabigatran etexilate may increase the anticoagulant activities of Enoxaparin.
Brinzolamide
Oliceridine
The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mepyramine is combined with Oliceridine.
Brinzolamide
Ziconotide
The risk or severity of CNS depression can be increased when Ziconotide is combined with Mepyramine.
Brinzolamide
Lasmiditan
The risk or severity of adverse effects can be increased when Mepyramine is combined with Lasmiditan.
Brinzolamide
Lefamulin
Lefamulin may increase the QTc-prolonging activities of Mepyramine.
Brinzolamide
Entrectinib
The risk or severity of QTc prolongation can be increased when Mepyramine is combined with Entrectinib.
Brinzolamide
Naphazoline
The risk or severity of CNS depression can be increased when Naphazoline is combined with Mepyramine.
Brinzolamide
Esketamine
The risk or severity of adverse effects can be increased when Mepyramine is combined with Esketamine.
Brinzolamide
Deoxyepinephrine
The therapeutic efficacy of Deoxyepinephrine can be increased when used in combination with Mepyramine.
Brinzolamide
Theodrenaline
The therapeutic efficacy of Theodrenaline can be increased when used in combination with Mepyramine.
Brinzolamide
Racepinephrine
The therapeutic efficacy of Racepinephrine can be increased when used in combination with Mepyramine.
Brinzolamide
Protokylol
The therapeutic efficacy of Protokylol can be increased when used in combination with Mepyramine.
Brinzolamide
Levonordefrin
The therapeutic efficacy of Levonordefrin can be increased when used in combination with Mepyramine.
Brinzolamide
Cannabinol
The risk or severity of adverse effects can be increased when Cannabinol is combined with Mepyramine.
Brinzolamide
Palmidrol
The risk or severity of adverse effects can be increased when Palmidrol is combined with Mepyramine.
Brinzolamide
Nabiximols
The risk or severity of adverse effects can be increased when Nabiximols is combined with Mepyramine.
Brinzolamide
WIN 55212-2
The risk or severity of adverse effects can be increased when WIN 55212-2 is combined with Mepyramine.
Brinzolamide
Surinabant
The risk or severity of adverse effects can be increased when Surinabant is combined with Mepyramine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3